Adverse Experience Information Management

advertisement

The Information Professional’s

Role in Product Safety

Jack Leitmeyer

Director, Adverse Experience Information

Management

Worldwide Product Safety

Merck & Co., Inc.

Agenda

Importance of Safety Surveillance

Regulatory Requirements

Role of the Adverse Experience (AE)

Information Professional

Future Opportunities

Importance of Safety Surveillance

Compliance with Government Laws and Regulations

Timely and Accurate Monitoring of the Safety Profile of Products

Limitation of human data in clinical trials

Small study populations

Restricted enrollment

Limited long term safety data

Widespread use of the product in the post-marketing environment

Benefit–risk safety profile changes over time

Adverse Experience Reporting to FDA

Pre-Approval - To IND

7 calendar day reports (telephone or facsimile)

Unexpected fatal or life-threatening experience associated with the use of the drug

15 calendar day reports to IND

From All Studies Worldwide (Serious, Drug-Related and Unexpected)

Findings from tests in laboratory animals suggesting a significant risk to humans (mutagenicity, teratogenicity, carcinogenicity)

Spontaneous Reports from Marketing Outside the U.S. (Serious and

Unexpected)

Reports in the scientific literature including unpublished manuscripts

(Serious and Unexpected)

Reports from foreign regulatory authorities (Serious and Unexpected)

Annual IND reports

From Studies Worldwide (Serious)

Adverse Experience Reporting to FDA

Post-Approval - To IND

15 calendar day reports to IND

From IND Studies (Serious, Drug-Related and

Unexpected)

Annual IND Report

From IND Studies (Serious)

Post-Approval - To NDA

15 calendar day reports to NDA

From All Studies Worldwide (Serious, Drug-Related and Unexpected)

Spontaneous Reports Worldwide (Serious and Unexpected)

Periodic Reports to NDA

Failure to Report

Pre-Approval - Termination of IND

21 CFR 312.44

Phase 1, 2 or 3

(b)(1)(vii) “The sponsor fails promptly to investigate and inform the Food and Drug Administration and all investigators of serious and unexpected adverse experiences in accordance with part 312 section 32 or fails to make any other report required under this part.”

Failure to Report

Post-Approval- Withdrawal of NDA

21 CFR 314.80 (K)

“If an applicant fails to establish and maintain records and

make reports required under this section FDA may

withdraw approval of the application and, thus, prohibit continued marketing of the drug product that is the subject of the application.”

Business Impact

Product

Monetary Loss

People

Penalties per Violation (Section 303

FD&C Act)

Fines and/or Jail

AE Information Management

Call Center

Data Mining

Applications

Clinical (MedDRA) /

Drug Dictionaries

Reports / Queries

AE database

Regulatory

Submission database

Investigator Portal

Clinical Trial data

Imaging System

Product Labeling

Clinical Literature

Clinical Risk Mgt.

Regulatory Agencies

Business Partners

Role of the AE Information Professional o Helpful Experience:

• Clinical terminology

• Worldwide safety regulations

• Technology

• Six Sigma Methodology

Role of the AE Information Professional o Safety Database Oversight o Reference Data Management o Document Management o Dictionary Management o Queries / Reports o Quality Control

Role of the AE Information Professional o Safety Database Oversight

• Information moving electronically between business partners and regulatory agencies

• Managing large datasets (over a million episodes)

• Mapping data fields across systems

• What data are required by safety department and regulatory agencies

• Algorithms for information flow

– Routing algorithms for data entry

– Routing to countries / agencies / business partners

– Rules for reportability

Role of the AE Information Professional o Safety Database Oversight – ICH E2B

• ICH = International Conference on Harmonization

• ICH E2B - Standardized essential data elements for electronic transmission of individual case safety reports:

1. Patient characteristics

2. Reactions/Events

3. Results of tests and procedures relevant to investigation of patient

4. Drug(s) Information (e.g., status, generic, tradename, marketing authorization number)

5. Narrative Case Summary (e.g., case summary, sender’s opinion of overall diagnosis/syndrome or reclassification of reporter terms)

Role of the AE Information Professional o Reference Data Management

• Clinical Trial protocol and site numbers

• Allocation schedules

• Drug formulations

• Routes of administration

• Country Lists

• NDA / IND numbers

• Journal Titles

• etc.

Role of the AE Information Professional o Document Management

• Record Retention Policy

• “Official” Files – paper / electronic records

• Patient Privacy

• Access to shared procedures

• Access to training material

Role of the AE Information Professional o Dictionary Management

• Medical Dictionary for Drug Regulatory

Activities (MedDRA*)

• Company procedures related to global standard dictionary

• Feedback to MedDRA Maintenance and

Support Services Organization (MSSO)

• Participation in Industry User Group

• Drug Dictionary

* MedDRA® is a registered trademark of the International Federation of

Pharmaceutical Manufacturers and Associations (IFPMA).

Role of the AE Information Professional o Queries / Reports

• Provide output for monitoring product safety and responding to safety questions.

• Ensure proper validation and testing (21 CFR Part 11)

• Information Specialist can provide input on:

• What data fields are available ?

• Search all versions, latest versions, or latest completed versions?

• Have the data values changed over time as regulations, procedures, and databases have changed ?

• What MedDRA terms / term groupings should be used to query the database ?

• What is the best format for the output?

• What is correct skill set required for writing and executing database queries?

Role of the AE Information Professional o Quality Control

• Data Entry sampling

• Coding Review

• Electronic submission tracking

• Compliance monitoring

Future Opportunities

o Evolving Regulations o Global Harmonization o Electronic Transfer of Data o Links to External Databases o Data Mining

Download